Complement dependent and independent liposome uptake by peritoneal macrophages: cholesterol content dependency.
The uptake mechanisms of liposomes by rat peritoneal macrophages (PMs) were investigated. Incubation of liposomes with fresh rat serum enhanced the uptake of liposomes depending on the liposome size and cholesterol (CH) content. The binding of liposomes was also enhanced by serum, and this increase depended on the size and CH content as in the case of liposome uptake, which suggested that the binding of opsonized liposomes with PMs govern the extent in liposome uptake. The rate constant for the internalization (k(int)) was calculated by measuring both uptake and binding. The k(int) cannot explain the variation of liposome uptake for different sizes and CH contents. The kint values for liposomes with high (44%) and medium (33%) CH contents were constant (2.5 h(-1)) , while those for liposomes with low (22%) CH content were significantly elevated (5-9 h(-1)). These results indicate the presence of at least two kinds of uptake mechanisms of liposomes. Treatment of serum with anti-C3 antibody completely inhibited the enhanced uptake of CH-high, large liposomes, which suggested that complement receptor-mediated phagocytosis may be an uptake mechanism for CH-high and -medium liposomes. In addition, complement-independent enhanced uptake was suggested for CH-low liposomes, since no inhibition was observed for CH-low liposomes by anti-C3 antibody and these liposomes were disintegrated in serum via complement-independent pathway. These results provided evidence that PMs take up liposomes via complement-dependent and independent mechanisms depending on the CH content of the liposomes.
Huong
T M
TM
Faculty of Pharmaceutical Sciences, The University of Tokushima, Japan.
Harashima
H
H
Kiwada
H
H
D000818:Animals; D000906:Antibodies; D002478:Cells, Cultured; D002784:Cholesterol / Q000737:chemistry / Q000493:pharmacokinetics*; D003176:Complement C3 / Q000276:immunology / Q000378:metabolism; D003165:Complement System Proteins / Q000378:metabolism*; D007700:Kinetics; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D017737:Macrophages, Peritoneal / Q000378:metabolism*; D008297:Male; D009895:Opsonin Proteins / Q000378:metabolism; D010587:Phagocytosis; D051381:Rats; D017208:Rats, Wistar
D000906:Antibodies; D003176:Complement C3; D008081:Liposomes; D009895:Opsonin Proteins; D003165:Complement System Proteins; D002784:Cholesterol